Breast Cancer MRI: What the Images Really Show

A recent study investigated whether a specific measurement taken from 3‑Tesla MRI scans—called the signal intensity ratio (SIR)—could inform doctors about a patient’s breast cancer subtype.

Study Design

• Population: Women who underwent MRI scans before any treatment.
• Measurement: SIR was calculated by comparing the brightness of each tumor to a nearby normal area on the scan.
• Data Collected: Tumor molecular subtype, including hormone‑receptor status and HER2 expression.

Findings

• Weak Association: The analysis revealed only a modest correlation between SIR values and tumor subtypes.
• Overlap in Values: While some groups showed slightly different average SIRs, the ranges overlapped considerably, preventing reliable subtype prediction based solely on this metric.
• Conclusion: SIR cannot replace genetic testing for determining breast cancer subtypes.

Implications

• Complementary Tool: SIR may provide a small additional piece of information when used alongside other imaging features and laboratory tests.
• Future Directions: Research could explore combining SIR with advanced MRI techniques or machine‑learning algorithms to enhance predictive accuracy.